Tempest Therapeutics (TPST) Operating Margin (QoQ) (2015 - 2018)
Powered by 
Analysis
Tempest Therapeutics (TPST) Operating Margin (QoQ) (2015 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -803,717.00 |
| Jun 30, 2018 | 39,370.00 |
| Mar 31, 2018 | 4.00 Mn |
| Dec 31, 2017 | -2.98 Mn |
| Sep 30, 2017 | 454,881.00 |
| Jun 30, 2017 | 180,873.00 |
| Mar 31, 2017 | -466,802.00 |
| Dec 31, 2016 | -885,955.00 |
| Sep 30, 2016 | 2,493.00 |
| Jun 30, 2016 | 503,292.00 |
| Mar 31, 2016 | -179,253.00 |
| Dec 31, 2015 | 1.08 Mn |
| Sep 30, 2015 | 3.36 Mn |
| Jun 30, 2015 | 5.48 Mn |